FDA Import Refusal 113-7841397-2/11/1 — Halo Pharmaceutical Canada Inc
The FDA refused shipment 113-7841397-2/11/1 from Halo Pharmaceutical Canada Inc (Canada) on Oct 28, 2019. The refused product falls under Drugs and Biologics — MEFLOQUINE HYDROCHLORIDE (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Oct 28, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62LCA49 MEFLOQUINE HYDROCHLORIDE (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL)
- Charges
- 75